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INTRODUCTION
The main intention of this research work is to design a library of 
novel coumarin derivatives by docking evaluation of the designed 
coumarin derivatives as squalene synthase inhibitor. Coumarins are 
the compounds which can be found in different levels all over the 
plant kingdom. Some significant coumarins were derived from several 
microorganisms such as from Streptomyces species [1]. Dyslipidemia is 
a main risk factor in the occurrence of coronary heart disease (CHD). In 
case of CHD, dyslipidemia is a major risk factor. According to the World 
Health Organization, there are around 4 million deaths per year due to 
the heart diseases which is caused by dyslipidemia [2,3].
Dyslipidemia leads to elevation of total cholesterol, low-density 
lipoproteins, high-density lipoprotein, and triglycerides. If the elevation of 
cholesterol occured due to lipoprotein then it is termed as hyperlipidemia, 
whereas elevation is due to triglycerides, low-density lipoprotein and 
high-density lipoprotein are called as atherogenic dyslipidemia [2,3].
With the sudden and stark increase in population growth rates the 
cardiovascular disease, it got affected the developing countries like 
India. By 2020, about 2.6 million Indians are estimated to die due 
to coronary heart failure. Among Indians, it has been shown that it 
occurs too early at least a period of 10 years or two earlier than their 
counterparts in developed countries [4].
Docking
Using docking method, we can find the favored orientation of one 
molecule to a second molecule when bound to each other to form a 
stable complex. It is commonly used to forecast the binding orientation 
of small drug molecule to their protein targets to predict the affinity 
and action of the small drug molecule. Thus, docking plays a significant 
role in the rational drug design. The aim of docking is to find the three-
dimensional (3D structure of the macromolecular complex of interest 
as it would happen in a living organism. Candidate structures which are 
potential can have produced by the process of docking [5].






SYBYL-X	 2.1	 software	 has	 used	 to	 carry	 out	 docking	 studies.	 This	
software for docking program helps to gain deep understanding of 
binding mode of the intended compounds and explains the effect 
of structural changes on the chosen protein in the direction of their 
inhibitory activities. The flow diagram for structure-based drug design 
is	shown	in	Fig.	1.	Crystallographic	data	of	the	selected	enzyme	were	




2.1, the protein has been developed in the basis of preparation module 
in the software. By this, the bond orders have been allocated, water 
and other residues have been removed, H atoms have added, and the 
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ABSTRACT
Objective: The importance of this research work is to design a library of novel coumarin derivatives by docking evaluation of the designed coumarin 
derivatives as squalene synthase inhibitor.
Methods: The	three-dimensional	structure	of	designed	molecules	of	squalene	synthase	inhibitors	was	collected	from	Protein	Data	Bank.	The	designed	
molecules	were	docked	onto	the	enzymes	that	are	squalene	synthase	inhibitor	-	3WCM,	3WCJ,	and	3Q2Z	protein	using	SYBYL-X	2.1.	Using	a	standard	
protocol, the protein was subjected to minimization and protomol generation.
Results: By this method, we visualized the possible binding and also estimated the protein interactions with our intended coumarin library, using 
SYBYL-X	2.1	software.	Into	the	active	site	of	the	selected	enzymes,	all	the	20	coumarins	were	docked	and	then	the	docking	scores	revealed	that	the	
compounds possess high affinity toward the selected enzymes.
Conclusion: With the help of virtual evaluation, we have elaborated a fast synthetically accessible coumarin-based compounds, and it is an advanced 
and original scaffold in the area of probable human squalene synthase inhibitors. Some of the developed compounds show better binding property 
than	ligand,	and	in	3q2Z,	the	compound	5d	shows	better	binding	property	than	the	protein.	Furthermore,	6g	and	6c	have	good	binding	property.	In	3	
WCM, the compound 6f has better property. In 3 WCJ, the compounds 6g and 6f show better binding property than the protein.
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Print - 0974-2441 protein	model	was	charged	with	AMBER7	FF99.	With	the	help	of	in silco 
screening, coumarin-based compounds have developed which are fast 
synthetically	 accessible	 compounds	 [7].	 It	 is	 a	 featuring	new	method	
in the case of potential human squalene synthase inhibitors. Especially, 
we have designed a set of compounds from a common scaffold having 
various groups attached to the coumarin ring, by considering both 
the synthetic accessibility and affinity with ligand binding domain of 





of 3Q2Z, 3WCJ, and 3WCM is shown in Figs. 2-4, respectively. At 2.38A 
resolution, this structure is resolved. We accomplished the minimization 
of human squalene synthase with a template using the prepare protein 
module	 in	 SYBYL	 [9].	 The	 ligand	 substructure	 was	 extracted,	 and	 all	
water molecules were separated. Explicit hydrogens were added to 
the	 protein,	 and	 protein	model	was	 charged	with	AMBER7	 FF99	 and	
ligand	 using	 Gasteiger-Marsili	 charges.	 Relaxation	 of	 the	 loop	 region	
and energy minimization was accomplished using 300 iterations with 
AMBER7	FF99	as	force	field	[10].
Protomol generation
Receptor active binding site (protomol) was generated around the 
cocrystallized	ligands	in	SYBYL	X.2.1	molecular	modeling	software	using	
default	parameters.	Ligand	was	extracted	from	the	protein.	The	active	
site was generated to fit the ligands similar in size to cocrystallized 




minimization was done using the software and preparation of ligand 
includes	the	addition	of	Gasteiger-Huckel	charges	and	polar	hydrogen	
[12]. A number of 20 coumarin derivative were used in the study, which 
were designed by in silco virtual screening. The library of compounds 
is listed in Table	 1.	 20	 ligands	 were	 drawn	 in	 Chem	 draw.	 Ligand	
preparation	is	a	beneficial	of	SYBYL	software	suit	that	links	the	tools	for	
creating 3D structures from 2D, searching for tautomers and performing 
a geometry minimization of ligands. The energy minimization of the 
ligands	was	performed	using	minimize	module	of	SYBYL	with	default	
parameters and applying molecular mechanics force fields [13].
Docking of ligands
SYBYL	 docking	 suite	 was	 helped	 for	 this	 study.	 The	 SYBYL	 docking	
processes carry out a set of graded examinations for positions of 
achievable ligand affinity within the binding site of a receptor. A 
rough arrangement and counting process are applied during the 
early examination step, come after torsional energy optimization on 
optimized potentials for liquid simulation-AA non-bonded potential 
energy grid for generating potential candidate poses. Selection of the 
final docked pose is done using a total score, which is a model energy 
function that joins the empirical and force field-based terms [14].
RESULTS AND DISCUSSION
Results of molecular docking
The method was used to visualize the probable binding and also to 
learn and estimate the protein interactions with our intended coumarin 
library.	Using	SYBYL-X	2.1	software,	the	docking	study	was	completed.	
In which, into the active site of the selected enzymes, all the 20 
coumarins	were	docked.	From	the	Brookhaven,	PDB	has	downloaded	
the crystal structure of the enzyme along with its cocrystallized ligand 
and was used for docking studies. 
Molecular docking studies on squalene synthase (3WCM)
The docking study of the designed substituted coumarin onto the active 
site	of	the	enzyme	squalene	synthase	(PDB:	3WCM)	was	encouraging	
(Fig. 8). The cocrystallized ligand ER4 ((3R)-3-{[2-benzyl-6-(3-
methoxypropoxy) pyridin- 3-yl] ethynyl}-1-azabicyclo [2.2.2] octan-3- 
ol)	showed	a	score	of	10.0858	Kcal/M	with	 the	 interactions	with	 the	
all-around	residues	Leu211A,	lle58A,	Leu76A,	Leu183A,	Val179A,	and	
Tyr73A	strongly	contributed	to	the	stabilization.
Fig. 1: Flow diagram for structure based drug design
Fig. 2: Graphical representation of 3Q2Z
Fig. 3: Graphical representation of 3WCJ
Fig. 4: Graphical representation of 3 WCM
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The docking study disclosed that the coumarin derivatives possessed 
high affinity in the directions 3WCM (Fig.	 9).	 The	 docking	 score	 of	
coumarin derivatives 5a–5j and 6a–6j toward 3WCM is shown in 
Table 2. Among the derivatives, compounds 6f and 6e displayed a 
good	 docking	 score	 of	 8.8778	 and	 7.6619	Kcal/M, respectively, show 
a better interaction with the protein squalene synthase, while the 
other coumarin derivatives exhibited a considerable score ranging 
from	3.8219	to	7.6015	Kcal/M	(docking	of	5	and	6	series	with	3WCM.
pdb is shown in Figs. 10 and 11, respectively, and also, 6g reference is 
shown in Fig. 12).
Fig. 5: Cocrystallized ligands of 3WCJ
Fig. 6: Cocrystallized ligands of 3Q2Z
Fig. 7: Cocrystallized ligands of 3WCM
Fig. 9: Conformationally analyzed and energy minimized 
structures aligned against common atoms interacting with 
protomol 3WCM
Fig. 10: Docking of 5 series with 3WCM.pdb
Fig. 8: Active binding in 3WCM
Fig. 11: Docking of 6 series with 3WCM.pdb
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Molecular docking studies on squalene synthase (3WCJ)
The study of the designed substituted coumarin onto the active site 
of	 squalene	 synthase	 (PDB:	 3WCJ)	 was	 encouraging	 (Fig.	 13).	 The	
cocrystallized ligand, E5S (3R)-3-({2-benzyl-6-[(3R,4S)-3-hydroxy-4- 




contributed to the stabilization.
The study displayed that the coumarin derivatives possessed high 
affinity in the direction of 3WCJ (Fig. 14). The docking score of 
coumarin derivatives 5a-5j and 6a-6j toward 3WCJ is shown in 
Table 3. Among the derivatives, compound 6g, 6f, and 6d showed a 
good	docking	score	of	8.355,	7.9677,	and	7.5437	Kcal/M, respectively, 
greater than that of the cocrystallized ligand 3WCJ, indicating a greater 
interaction with the protein squalene synthase and spotlighting 
its capability to prevent the same and create a remarkable anti-
dyslipidemia action, while the other coumarin derivatives showed 
a	 considerable	 score	 ranging	 from	 4.0224	 to	 7.3892	 Kcal/M.	 The	
Table 1: Library of compounds























Fig. 12: 6g reference
(Contd...)
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docking of 5 and 6 series with 3WCJ.pdb is shown in Figs. 15 and 16, 
respectively.
Molecular docking studies on squalene synthase (3Q2Z)
The study of the designed substituted coumarin onto the active site 
of	 the	 enzyme	 squalene	 synthase	 (PDB:	 3Q2Z)	 was	 encouraging	
(Fig.	17).	The	cocrystallized	 ligand,	D9A,	N-{[(3R,5S)-7-chloro-5-(2,3-
dimethoxyphenyl)-1-(2,2-dimethylpropyl)-2-oxo-1,2,3,5-tetrahydro-
4,1-benzoxazepin-3-yl]acetyl}-L-aspartic	 acid,	 shows	 a	 score	 after	
docking,	 i.e.,7.7031	 cal/M	 with	 the	 influence	 with	 the	 all-around	
the	 residues	 Val179A,	 Ala176A,	 Phen288A,	 Leu183A,	 Pro292A,	 and	
Phen288A	strongly	contributed	to	the	stabilization.
Conformationally analyzed and energy minimized structures aligned 
against common atoms interacting with protomol 3Q2Z are shown 
in Fig. 18. Docking score of coumarin derivatives 5a–5j and 6a–6j 
toward 3Q2Z is shown in Table 4. The study disclosed that, among the 
derivatives,	 compound	 5d	 showed	 a	 better	 score	 of	 8.0496	 Kcal/M, 
respectively, greater than that of the cocrystallized ligand 3Q2Z which 
shows a great interaction with the protein squalene synthase and 
draws special attention to its ability to inhibit the same and creates 
an important anti-dyslipidemic action, while the other coumarin 
derivatives showed a considerable docking score extend between 
3.924	and	7.5023	Kcal/M.	The	docking	of	5	and	series	with	3Q2Z.pdb	is	
shown in Figs.	19	and	20,	respectively.
Fig. 13: Active binding in 3WCJ
Fig. 14: Conformationally analysed and energy minimized 
structures aligned against atoms interacting with protomol 3WCJ
Fig. 15: Docking of 5 series with 3WCJ.pdb
Fig. 16: Docking of 6 series with 3WCJ.pdb
Fig. 17: Active binding in 3Q2Z
Fig. 18: Conformationally analyzed and energy minimized 
structures aligned against common atoms interacting with 
protomol 3Q2Z
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Table 3: Docking score of coumarin derivatives 5a–5j and 6a–6j 
toward 3WCJ
Name Total score Crash Polar
3WCJ 7.4301 −1.8869 3.0632
5A 5.7669 −1.0303 0.1536
5B 7.0856 −1.5897 0.9592
5C 6.7155 −1.4323 2.0573
5D 6.5133 −0.725 1.3759
5E 6.3168 −1.5314 2.0522
5F 6.3762 −1.2533 4.3744
5G 5.7789 −1.2797 3.2303
5H 5.0926 −0.967 0
5I 4.3926 −0.5829 0.1326
5J 4.0224 −0.8375 1.0627
6A 7.3178 −3.0337 1.6263
6B 7.1507 −2.9978 2.1212
6C 7.1805 −4.5957 0.8395
6D 7.5437 −4.5924 1.2254
6E 7.3892 −1.6322 2.1942
6F 7.9677 −2.3664 5.8064
6G 8.355 −3.4986 5.3276
6H 6.8857 −2.0305 2.0567
6I 6.3393 −1.441 4.0459
6J 5.4802 −0.8153 1.0872
CONCLUSION
With the help of virtual evaluation, we have elaborated fast synthetically 
accessible coumarin-based compounds, and it is an advanced and 
original scaffold in the area of probable human squalene synthase 
inhibitors. Especially, we have designed a group of compounds from a 
common scaffold having various groups attached to the coumarin ring, 
by considering the both the compatibility with ligand binding domain 
and synthetic accessibility of squalene synthase. Some of the developed 
compounds show better binding property than ligand, and in 3q2Z 
(score:	7.7031),	the	compound	5d	shows	better	binding	property	than	
the	protein	with	a	score	of	8.0496.	Furthermore,	6g	and	6c	have	good	
binding property. In 3WCM (10.0858), the compound 6f has a better 
property	with	a	score	of	8.355.	 In	3WCJ	(7.4301),	 the	compounds	6g	
and 6f show better binding property than the protein with score of 
8.355	and	7.9677,	respectively.
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Table 4: Docking score of coumarin derivatives 5a–5j and 6a–6j 
toward 3Q2Z
Name Total score Crash Polar
3Q2Z 7.7031 −1.8378 2.3055
5a 5.7563 −0.6161 0.0008
5b 6.6484 −1.0744 1.8029
5c 5.8023 −0.8269 0.0118
5d 8.0496 −1.2195 2.5386
5e 6.7664 −2.0112 1.9912
5f 5.1324 −0.7698 2.7422
5g 5.0874 −2.1981 1.869
5h 6.1545 −0.9184 2.1254
5i 4.4302 −1.6642 2.1496
5j 3.6924 −0.6029 2.0317
6a 6.2653 −1.2328 1.9052
6b 6.2263 −1.3705 1.8469
6c 6.9278 −1.1291 1.494
6d 6.3276 −1.0056 3.04
6e 6.4225 −2.0735 1.3061
6f 6.5614 −1.138 4.7483
6g 7.5023 −1.7564 4.1302
6h 6.3419 −1.9915 2.6184
6i 6.0045 −1.213 1.2191
6j 5.0727 −0.9799 1.714
Table 2: Docking score of coumarin derivatives 5a–5j and 6a–6j 
toward 3WCM
Name Total score Crash Polar
3WCM 10.0858 −1.0032 0
5a 6.0303 −0.9745 0.6693
5b 6.2748 −1.0513 0.8472
5c 6.4401 −0.9485 1.5438
5d 6.7267 −1.4343 1.1061
5e 6.7664 −2.0112 1.9912
5f 6.0301 −1.874 3.6454
5g 6.1686 −0.9854 2.6787
5h 5.7272 −0.9888 0.7757
5i 4.6311 −0.9516 0.7607
5j 3.8219 −0.8645 0.9766
6a 6.8195 −1.9221 0.9764
6b 7.4204 −1.906 2.3131
6c 7.6015 −1.4632 1.0385
6d 7.3004 −3.1822 4.9339
6e 7.6619 −1.6783 1.0828
6f 8.8778 −2.8572 4.8447
6g 6.9703 −3.1642 3.4574
6h 6.6916 −2.8632 2.2597
6i 6.1307 −2.21 2.3035
6j 5.8351 −1.7756 3.0013
Fig. 19: Docking of 5 series with 3Q2Z.pdb
Fig. 20: Docking of 6 series with 3Q2Z.pdb
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